부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Bukwang Pharm. participates in APASL STC 2016, largest inte..
The GI (gastrointestinal) department of Bukwang Pharmaceutical Co., Ltd. partici..
2016.06.01
Company news | Bukwang Pharm. attends Spring Symposium of Korean Dermatolo..
Bukwang Pharmaceutical Co., Ltd. announced attendance of the 68th Spring Symposi..
2016.05.30
Company news | Bukwang Pharm. invests 2 mil USD to Acer Therapeutics Inc., ..
Bukwang Pharmaceutical Co., Ltd. announced that they agreed to invest 2 mil. USD..
2016.05.20
Company news | Bukwang Pharm. receives orphan drug designation for apatinib..
Bukwang Pharmaceutical Co., Ltd. announced receipt of orphan drug designation fo..
2016.02.15
Company news | Bukwang Pharm leading the market for generics of Baraclude
Since patent expiry of Baraclude on October 10th, 62 generics have been launched..
2015.12.17
Company news | Bukwang Pharm. hosts the 2nd TVM Capital Asia Conference – p..
Bukwang Pharm. announced that it hosted the second TVM Capital Asia Conference a..
2015.10.30
1
2
3
4
5